Allele frequencies of BRAF<i>V600</i> mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanomaImke Satzger, Ralf Gutzmer, B. Völker et al.|Oncotarget|2015Cited by 29
Salvage therapy after failure from anti-PD-1 single agent treatment: A Study by the German ADOReg melanoma registry.Michael Weichenthal, Peter Mohr, Selma Ugurel et al.|Journal of Clinical Oncology|2019Cited by 26
PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanomaKatrin Schaper‐Gerhardt, Ralf Gutzmer, Steven Okoye et al.|European Journal of Cancer|2017Cited by 16